Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China.

Min LiYuxin CaoHao HuangGang QinMinjie ChuMeiyin ZouXun Zhuang

Published in: BMC public health (2023)

DTG-based regimen for treatment-naive patients is likely to be cost-effective and deserve wider implementation in China. This study strongly suggests the centralized procurement of DTG to minimize cost and maximize cost-effectiveness.

Keyphrases

hiv infected
end stage renal disease
healthcare
primary care
newly diagnosed
chronic kidney disease
prognostic factors
combination therapy
patient reported outcomes
drug induced